COVID-19 Diagnostics: Global Markets
REPORT SCOPE:
The current report offers a detailed picture of the market for COVID-19 diagnostics.
COVID-19 is an infectious disease that is caused by the coronavirus and primarily affects the lungs.
This report highlights the current and future market potential for COVID-19 diagnostics and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities and trends in the market. The report also covers market projections through 2027, as well as market shares for key market players.
This report details market shares for COVID-19 diagnostics based on type, technology, end-user and geography. Based on type, the market is segmented into molecular tests and serology tests segments. Based on technology, the market is segmented into reverse transcription polymerase chain reaction (RT-PCR), isothermal amplification, clustered regularly interspaced short palindromic repeats (CRISPR), enzyme-linked immunosorbent assay (ELISA), hybridization and others.
By geography, the market has been segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. Detailed analyses of major countries (the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and India) are covered in regional segments. For market estimates, data has been provided for 2020 as the base year, with forecasts for 2021 through 2027. Estimated values are based on diagnostics manufacturers' total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.
REPORT INCLUDES:
The current report offers a detailed picture of the market for COVID-19 diagnostics.
COVID-19 is an infectious disease that is caused by the coronavirus and primarily affects the lungs.
This report highlights the current and future market potential for COVID-19 diagnostics and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities and trends in the market. The report also covers market projections through 2027, as well as market shares for key market players.
This report details market shares for COVID-19 diagnostics based on type, technology, end-user and geography. Based on type, the market is segmented into molecular tests and serology tests segments. Based on technology, the market is segmented into reverse transcription polymerase chain reaction (RT-PCR), isothermal amplification, clustered regularly interspaced short palindromic repeats (CRISPR), enzyme-linked immunosorbent assay (ELISA), hybridization and others.
By geography, the market has been segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. Detailed analyses of major countries (the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and India) are covered in regional segments. For market estimates, data has been provided for 2020 as the base year, with forecasts for 2021 through 2027. Estimated values are based on diagnostics manufacturers' total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.
REPORT INCLUDES:
- 56 data tables and 39 additional tables
- An overview of the global market for COVID-19 diagnostics
- Estimation of the market size of global COVID-19 diagnostics and analyses of global market trends, with estimated data from 2020, 2021 and projections of compound annual growth rates (CAGRs) through 2027
- Explanation of factors driving and restraining the growth of global COVID-19 diagnostics market
- A look at the Case-Fatality Rate (CFR), global confirmed cases and confirmed deaths due to COVID-19 and COVID-19 clinical trial landscape
- Information on potential targets for COVID-19 drug development such as Basigin (CD147), C-C Chemokine Receptor Type 5 (CCR5) and many more
- Details about collaboration between organizations and governments to stop this pandemic and recent research and development activities for COVID-19
- Market share analysis of the key companies of the industry, their strategic profiling and key competitive landscape
- Detailed company profiles of market leading participants, including Abbott, Danaher Corp., Bio-Rad Laboratories Inc., F. Hoffman-La Roche Ltd., and Thermo Fisher Scientific Inc.
CHAPTER 1 INTRODUCTION
Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
CHAPTER 3 MARKET AND TECHNOLOGY BACKGROUND
Overview of Pandemic Outbreaks
History of Outbreak
Symptoms of COVID-19
Progression of COVID-19
Incubation Period
Epidemiology
Case-Fatality Rate (CFR)
Global Confirmed Cases and Confirmed Deaths Due to COVID-19
Lessons Learned from the Past
Healthcare Worker Infections
Collaboration Between Organizations and Governments
Spread of the Disease
CHAPTER 4 COVID-19 AND R&D EFFORTS
Potential Targets for COVID-19 Drug Development
Basigin (CD147)
C-C Chemokine Receptor Type 5 (CCR5)
Envelope Protein (E) (SARS-CoV-2; COVID-19)
Epithelial Sodium Channel (ENaC)
Histamine N-Methyltransferase (HMT)
Interleukin-6 Receptor Subunit ? (IL-6RA)
Membrane Glycoprotein (M) (SARS-CoV-2; COVID-19)
Nucleocapsid (N) (SARS-CoV-2; COVID-19)
Research and Development on COVID-19
Need to Reinvent Ventilators
COVID-19 Clinical Trial Landscape
CHAPTER 5 ECONOMIC IMPACT OF COVID-19
Impact of Coronavirus on the Global Economy
Government Expenditures on COVID-19
Predictions for the Global Economy
Quick Recovery
Global Slowdown
Pandemic and Recession
Social Impact of COVID-19
CHAPTER 6 IMPACT OF COVID-19 ON THE HEALTHCARE INDUSTRY
Impact of COVID-19 on Pharma Supply Chains
Disruption of Clinical Trials
Impact on Insurance Providers
Impact on Health Technology Assessment
Threat to Healthcare Acquisitions
CHAPTER 7 MARKET DYNAMICS
Market Drivers
Overview
Increasing Number of COVID 19 Cases
Government and Private Funds to Support Research and Development of COVID-19 Test Kits and Vaccine
Rising Number of Emergency Use Authorizations (EUA) for Diagnostic Kits and Devices
Growing Geriatric Populations
Key Developments and Support by Non-medical Device/Diagnostic Companies
Market Restraints
Restrictions on Export of Diagnostic Kits
Accuracy of Test Results
Market Opportunities
Development of Quick, Accurate and Affordable Tests
Strategic R&D Initiatives
CHAPTER 8 MARKET BREAKDOWN BY TYPE
Global Market for COVID-19 Diagnostics by Type
Molecular Tests
Market Size and Forecast
Serology Tests
Market Size and Forecast
CHAPTER 9 MARKET BREAKDOWN BY TECHNOLOGY
Global Market for COVID-19 Diagnostics by Technology
RT-PCR
Market Size and Forecast
Isothermal Amplification
Market Size and Forecast
CRISPR
Market Size and Forecast
ELISA
Market Size and Forecast
Hybridization
Market Size and Forecast
Others
Market Size and Forecast
CHAPTER 10 MARKET BREAKDOWN BY END USER
Global Market for COVID-19 Diagnostics by End User
Hospitals
Market Size and Forecast
Public Health Laboratories
Market Size and Forecast
Private Laboratories
Market Size and Forecast
Others
Market Size and Forecast
CHAPTER 11 MARKET BREAKDOWN BY REGION
Global Market for COVID-19 Diagnostics by Region
Europe
United Kingdom
Spain
Germany
Italy
France
Rest of Western Europe
Eastern Europe
North America
United States
Canada
Asia-Pacific
India
Australia
South Korea
Japan
China
Rest of Asia-Pacific
Latin America
Market Size and Forecast
Market Analysis
Middle East and Africa
Market Size and Forecast
CHAPTER 12 REGULATORY STRUCTURE OF THE COVID-19 DIAGNOSTICS INDUSTRY
Coronavirus Treatment Acceleration Program (CTAP)
Clinical Trials Being Conducted During COVID-19 Pandemic
Drug Shortages Response
National Regulatory Agencies for Ongoing Clinical Trials During the COVID-19 Pandemic
U.S. FDA
Medicines and Healthcare Products Regulatory Agency (U.K.)
European Medicines Agency
CHAPTER 13 COMPETITIVE LANDSCAPE
Global Company Ranking Analysis
Insights into the Global Market for COVID 19 Diagnostics
Competitors
Mergers and Acquisitions
Agreements, Contracts, Collaborations and Partnerships
New Product Approvals
CHAPTER 14 COMPANY PROFILES
Major Diagnostics Manufacturers
ABBOTT
BECTON, DICKINSON AND CO.
BIOMERIEUX SA
BIO-RAD LABORATORIES INC.
DANAHER CORP.
F. HOFFMANN-LA ROCHE LTD.
GENMARK DIAGNOSTICS INC.
HOLOGIC INC.
QIAGEN NV
SIEMENS HEALTHCARE AG
THERMO FISHER SCIENTIFIC INC.
Other Prominent Companies
1DROP DIAGNOSTICS
CEPHEID
LABORATORY CORPORATION OF AMERICA HOLDINGS
PERKINELMER INC.
QUEST DIAGNOSTICS
VEREDUS LABORATORIES
CHAPTER 15 APPENDIX: ACRONYMS
Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
CHAPTER 3 MARKET AND TECHNOLOGY BACKGROUND
Overview of Pandemic Outbreaks
History of Outbreak
Symptoms of COVID-19
Progression of COVID-19
Incubation Period
Epidemiology
Case-Fatality Rate (CFR)
Global Confirmed Cases and Confirmed Deaths Due to COVID-19
Lessons Learned from the Past
Healthcare Worker Infections
Collaboration Between Organizations and Governments
Spread of the Disease
CHAPTER 4 COVID-19 AND R&D EFFORTS
Potential Targets for COVID-19 Drug Development
Basigin (CD147)
C-C Chemokine Receptor Type 5 (CCR5)
Envelope Protein (E) (SARS-CoV-2; COVID-19)
Epithelial Sodium Channel (ENaC)
Histamine N-Methyltransferase (HMT)
Interleukin-6 Receptor Subunit ? (IL-6RA)
Membrane Glycoprotein (M) (SARS-CoV-2; COVID-19)
Nucleocapsid (N) (SARS-CoV-2; COVID-19)
Research and Development on COVID-19
Need to Reinvent Ventilators
COVID-19 Clinical Trial Landscape
CHAPTER 5 ECONOMIC IMPACT OF COVID-19
Impact of Coronavirus on the Global Economy
Government Expenditures on COVID-19
Predictions for the Global Economy
Quick Recovery
Global Slowdown
Pandemic and Recession
Social Impact of COVID-19
CHAPTER 6 IMPACT OF COVID-19 ON THE HEALTHCARE INDUSTRY
Impact of COVID-19 on Pharma Supply Chains
Disruption of Clinical Trials
Impact on Insurance Providers
Impact on Health Technology Assessment
Threat to Healthcare Acquisitions
CHAPTER 7 MARKET DYNAMICS
Market Drivers
Overview
Increasing Number of COVID 19 Cases
Government and Private Funds to Support Research and Development of COVID-19 Test Kits and Vaccine
Rising Number of Emergency Use Authorizations (EUA) for Diagnostic Kits and Devices
Growing Geriatric Populations
Key Developments and Support by Non-medical Device/Diagnostic Companies
Market Restraints
Restrictions on Export of Diagnostic Kits
Accuracy of Test Results
Market Opportunities
Development of Quick, Accurate and Affordable Tests
Strategic R&D Initiatives
CHAPTER 8 MARKET BREAKDOWN BY TYPE
Global Market for COVID-19 Diagnostics by Type
Molecular Tests
Market Size and Forecast
Serology Tests
Market Size and Forecast
CHAPTER 9 MARKET BREAKDOWN BY TECHNOLOGY
Global Market for COVID-19 Diagnostics by Technology
RT-PCR
Market Size and Forecast
Isothermal Amplification
Market Size and Forecast
CRISPR
Market Size and Forecast
ELISA
Market Size and Forecast
Hybridization
Market Size and Forecast
Others
Market Size and Forecast
CHAPTER 10 MARKET BREAKDOWN BY END USER
Global Market for COVID-19 Diagnostics by End User
Hospitals
Market Size and Forecast
Public Health Laboratories
Market Size and Forecast
Private Laboratories
Market Size and Forecast
Others
Market Size and Forecast
CHAPTER 11 MARKET BREAKDOWN BY REGION
Global Market for COVID-19 Diagnostics by Region
Europe
United Kingdom
Spain
Germany
Italy
France
Rest of Western Europe
Eastern Europe
North America
United States
Canada
Asia-Pacific
India
Australia
South Korea
Japan
China
Rest of Asia-Pacific
Latin America
Market Size and Forecast
Market Analysis
Middle East and Africa
Market Size and Forecast
CHAPTER 12 REGULATORY STRUCTURE OF THE COVID-19 DIAGNOSTICS INDUSTRY
Coronavirus Treatment Acceleration Program (CTAP)
Clinical Trials Being Conducted During COVID-19 Pandemic
Drug Shortages Response
National Regulatory Agencies for Ongoing Clinical Trials During the COVID-19 Pandemic
U.S. FDA
Medicines and Healthcare Products Regulatory Agency (U.K.)
European Medicines Agency
CHAPTER 13 COMPETITIVE LANDSCAPE
Global Company Ranking Analysis
Insights into the Global Market for COVID 19 Diagnostics
Competitors
Mergers and Acquisitions
Agreements, Contracts, Collaborations and Partnerships
New Product Approvals
CHAPTER 14 COMPANY PROFILES
Major Diagnostics Manufacturers
ABBOTT
BECTON, DICKINSON AND CO.
BIOMERIEUX SA
BIO-RAD LABORATORIES INC.
DANAHER CORP.
F. HOFFMANN-LA ROCHE LTD.
GENMARK DIAGNOSTICS INC.
HOLOGIC INC.
QIAGEN NV
SIEMENS HEALTHCARE AG
THERMO FISHER SCIENTIFIC INC.
Other Prominent Companies
1DROP DIAGNOSTICS
CEPHEID
LABORATORY CORPORATION OF AMERICA HOLDINGS
PERKINELMER INC.
QUEST DIAGNOSTICS
VEREDUS LABORATORIES
CHAPTER 15 APPENDIX: ACRONYMS
LIST OF TABLES
Summary Table B: Global Market for COVID-19 Diagnostics, by Technology, Through 2027
Summary Table A: Global Market for COVID-19 Diagnostics, by Type, Through 2027
Table 1: COVID-19 Symptoms, by Percentage of Patients
Table 2: COVID-19 CFR, by Region, as of March 2020
Table 3: COVID-19 CFR, by Selected Countries, as of March 2020
Table 4: COVID-19 Confirmed Cases and Deaths, by Country, as of April 15, 2020
Table 5: COVID-19 Cases and Deaths per 1 Million Population, by Selected Country
Table 6: Total Number of Diagnostic Tests Performed per 1 Million Population, by Selected Country
Table 7: COVID-19 Therapeutic Interventions in Development, by Biopharmaceutical Company Collaborations
Table 8: COVID-19 Therapeutics in Development, by Biopharmaceutical Company
Table 9: COVID-19 Vaccines in Development, by Biopharmaceutical Companies in Collaboration
Table 10: COVID-19 Vaccines in Development, by Biopharmaceutical Company
Table 11: Modifiable Breathing Devices Eligible for Emergency Use Authorization (EUA), by Company
Table 12: Clinical Trials on COVID-19, by Phase
Table 13: Clinical Trials on COVID-19, by Intervention
Table 14: Clinical Trials on COVID-19, by Country
Table 15: Interim Economic Outlook Forecasts, by Country/Region, as of March 2, 2020
Table 16: Expenditures on COVID-19 Crisis
Table 17: Disruption of Clinical Trials Due to COVID-19, by Therapeutic Area
Table 18: Selected Pending Acquisitions in the Healthcare Industry
Table 19: Global COVID 19 Virus Scenario, as of May 20, 2020
Table 20: Test Kit Manufacturers and EUA Authorizations
Table 21: Global Market for COVID-19 Diagnostics, by Type, Through 2027
Table 22: U.S. FDA Revised Policy for COVID-19 Molecular Tests During the Public Health Emergency, by Company
Table 23: Global Market for COVID-19 Molecular Tests, by Region, Through 2027
Table 24: U.S. FDA Revised Policy for COVID-19 Serological Tests During the Public Health Emergency, by Company
Table 25: Global Market for COVID-19 Serological Tests, by Region, Through 2027
Table 26: Global Market for COVID-19 Diagnostics, by Technology, Through 2027
Table 27: Global Market for COVID-19 RT-PCR Diagnostics, by Region, Through 2027
Table 28: U.S. FDA Revised Policy for COVID-19 During the Public Health Emergency: Usage of Isothermal Amplification Technology, by Company
Table 29: Global Market for COVID-19 Isothermal Amplification Diagnostics, by Region, Through 2027
Table 30: Global Market for COVID-19 CRISPR Diagnostics, by Region, Through 2027
Table 31: U.S. FDA Revised Policy for COVID-19 during Public Health Emergency: Usage of ELISA, by Company
Table 32: Global Market for COVID-19 ELISA Diagnostics, by Region, Through 2027
Table 33: Global Market for COVID-19 Hybridization Diagnostics, by Region, Through 2027
Table 34: Global Market for Other Types of COVID-19 Diagnostics, by Region, Through 2027
Table 35: Global Market for COVID-19 Diagnostics, by End User, Through 2027
Table 36: Global Market for COVID-19 Diagnostics in Hospitals, by Region, Through 2027
Table 37: Global Market for COVID-19 Diagnostics in Public Health Laboratories, by Region, Through 2027
Table 38: Global Market for COVID-19 Diagnostics in Private Laboratories, by Region, Through 2027
Table 39: Global Market for COVID-19 Diagnostics in the Other End-User Segment, by Region, Through 2027
Table 40: Global Market for COVID-19 Diagnostics, by Region, Through 2027
Table 41: European Market for COVID-19 Diagnostics, by Sub-region, Through 2027
Table 42: European Market for COVID-19 Diagnostics, by Type, Through 2027
Table 43: Western European Market for COVID-19 Diagnostics, by Country, Through 2027
Table 44: North American Market for COVID-19 Diagnostics, by Type, Through 2027
Table 45: North American Market for COVID-19 Diagnostics, by Country, Through 2027
Table 46: Asia-Pacific Market for COVID-19 Diagnostics, by Type, Through 2027
Table 47: Asia-Pacific Market for COVID-19 Diagnostics, by Country, Through 2027
Table 48: Latin American Market for COVID-19 Diagnostics, by Type, Through 2027
Table 49: Middle Eastern and African Market for COVID-19 Diagnostics, by Type, Through 2027
Table 50: Global Company Ranking within the Market for COVID-19 Diagnostics, 2020
Table 51: Competitors in the Market for COVID-19 Diagnostics
Table 52: Recent Acquisitions by Players in the Market for COVID-19 Diagnostics, 2016 and 2017
Table 53: Recent Contracts in the Market for COVID-19 Diagnostics, 2020
Table 54: Recent Product Approvals on COVID-19 Diagnostics, 2020
Table 55: Abbott: Financials, 2016-2019
Table 56: Abbott: Product Portfolio, by Business Segment
Table 57: Abbott: Rhythm Management Products, 2018
Table 58: Abbott: Recent Developments, April 2015-April 2020
Table 59: Becton, Dickinson and Co.: Financials, 2019
Table 60: Becton, Dickinson and Co.: Product Portfolio
Table 61: Becton, Dickinson and Co.: Bioscience Cell Culture Product Portfolio
Table 62: Becton, Dickinson and Co.: Recent Developments, August 2015-April 2020
Table 63: BioMerieux SA: Financials, 2018
Table 64: BioMerieux SA: Products and Services
Table 65: BioMerieux SA: Recent Developments, November 2018-March 2020
Table 66: Bio-Rad Laboratories Inc.: Financials, 2019
Table 67: Bio-Rad Laboratories Inc.: Products and Services
Table 68: Bio-Rad Laboratories Inc.: Recent Developments, January 2018-May 2020
Table 69: Danaher Corp.: Product Portfolio
Table 70: Danaher Corp.: Financials, 2019
Table 71: Danaher Corp.: Products and Services
Table 72: Danaher Corp.: Recent Developments, August 2015-March 2020
Table 73: F. Hoffmann-La Roche Ltd.: Financials, 2019
Table 74: F. Hoffmann-La Roche Ltd.: Revenues, by Segment, 2016-2018
Table 75: F. Hoffmann-La Roche Ltd.: Revenue, by Diagnostic Segment, 2016-2018
Table 76: F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 77: F. Hoffmann-La Roche Ltd.: Diagnostics Patient Monitoring Product Portfolio
Table 78: F. Hoffmann-La Roche Ltd.: Recent Developments, January 2015-April 2020
Table 79: GenMark Diagnostics Inc.: Key Products
Table 80: GenMark Diagnostics Inc.: COVID Diagnostic Product
Table 81: Glenmark Diagnostics Inc.: Financials, 2019
Table 82: Glenmark Diagnostics Inc.: Recent Developments, March 2020
Table 83: Hologic Inc.: Financials, 2019
Table 84: Hologic Inc.: Recent Developments and Strategies, March 2017-March 2020
Table 85: Qiagen NV: Financials, 2016 and 2017
Table 86: Qiagen NV: Products and Services
Table 87: Siemens Healthcare AG: Key Products
Table 88: Siemens Healthcare AG: Product Segments
Table 89: Siemens Healthcare AG: Financials, 2019
Table 90: Siemens Healthcare AG: Recent Developments, March 2016-March 2020
Table 91: Thermo Fisher Scientific Inc.: Financials, 2018-2019
Table 92: Thermo Fisher Scientific Inc.: Products and Services
Table 93: Acronyms Used in This Report
Summary Table B: Global Market for COVID-19 Diagnostics, by Technology, Through 2027
Summary Table A: Global Market for COVID-19 Diagnostics, by Type, Through 2027
Table 1: COVID-19 Symptoms, by Percentage of Patients
Table 2: COVID-19 CFR, by Region, as of March 2020
Table 3: COVID-19 CFR, by Selected Countries, as of March 2020
Table 4: COVID-19 Confirmed Cases and Deaths, by Country, as of April 15, 2020
Table 5: COVID-19 Cases and Deaths per 1 Million Population, by Selected Country
Table 6: Total Number of Diagnostic Tests Performed per 1 Million Population, by Selected Country
Table 7: COVID-19 Therapeutic Interventions in Development, by Biopharmaceutical Company Collaborations
Table 8: COVID-19 Therapeutics in Development, by Biopharmaceutical Company
Table 9: COVID-19 Vaccines in Development, by Biopharmaceutical Companies in Collaboration
Table 10: COVID-19 Vaccines in Development, by Biopharmaceutical Company
Table 11: Modifiable Breathing Devices Eligible for Emergency Use Authorization (EUA), by Company
Table 12: Clinical Trials on COVID-19, by Phase
Table 13: Clinical Trials on COVID-19, by Intervention
Table 14: Clinical Trials on COVID-19, by Country
Table 15: Interim Economic Outlook Forecasts, by Country/Region, as of March 2, 2020
Table 16: Expenditures on COVID-19 Crisis
Table 17: Disruption of Clinical Trials Due to COVID-19, by Therapeutic Area
Table 18: Selected Pending Acquisitions in the Healthcare Industry
Table 19: Global COVID 19 Virus Scenario, as of May 20, 2020
Table 20: Test Kit Manufacturers and EUA Authorizations
Table 21: Global Market for COVID-19 Diagnostics, by Type, Through 2027
Table 22: U.S. FDA Revised Policy for COVID-19 Molecular Tests During the Public Health Emergency, by Company
Table 23: Global Market for COVID-19 Molecular Tests, by Region, Through 2027
Table 24: U.S. FDA Revised Policy for COVID-19 Serological Tests During the Public Health Emergency, by Company
Table 25: Global Market for COVID-19 Serological Tests, by Region, Through 2027
Table 26: Global Market for COVID-19 Diagnostics, by Technology, Through 2027
Table 27: Global Market for COVID-19 RT-PCR Diagnostics, by Region, Through 2027
Table 28: U.S. FDA Revised Policy for COVID-19 During the Public Health Emergency: Usage of Isothermal Amplification Technology, by Company
Table 29: Global Market for COVID-19 Isothermal Amplification Diagnostics, by Region, Through 2027
Table 30: Global Market for COVID-19 CRISPR Diagnostics, by Region, Through 2027
Table 31: U.S. FDA Revised Policy for COVID-19 during Public Health Emergency: Usage of ELISA, by Company
Table 32: Global Market for COVID-19 ELISA Diagnostics, by Region, Through 2027
Table 33: Global Market for COVID-19 Hybridization Diagnostics, by Region, Through 2027
Table 34: Global Market for Other Types of COVID-19 Diagnostics, by Region, Through 2027
Table 35: Global Market for COVID-19 Diagnostics, by End User, Through 2027
Table 36: Global Market for COVID-19 Diagnostics in Hospitals, by Region, Through 2027
Table 37: Global Market for COVID-19 Diagnostics in Public Health Laboratories, by Region, Through 2027
Table 38: Global Market for COVID-19 Diagnostics in Private Laboratories, by Region, Through 2027
Table 39: Global Market for COVID-19 Diagnostics in the Other End-User Segment, by Region, Through 2027
Table 40: Global Market for COVID-19 Diagnostics, by Region, Through 2027
Table 41: European Market for COVID-19 Diagnostics, by Sub-region, Through 2027
Table 42: European Market for COVID-19 Diagnostics, by Type, Through 2027
Table 43: Western European Market for COVID-19 Diagnostics, by Country, Through 2027
Table 44: North American Market for COVID-19 Diagnostics, by Type, Through 2027
Table 45: North American Market for COVID-19 Diagnostics, by Country, Through 2027
Table 46: Asia-Pacific Market for COVID-19 Diagnostics, by Type, Through 2027
Table 47: Asia-Pacific Market for COVID-19 Diagnostics, by Country, Through 2027
Table 48: Latin American Market for COVID-19 Diagnostics, by Type, Through 2027
Table 49: Middle Eastern and African Market for COVID-19 Diagnostics, by Type, Through 2027
Table 50: Global Company Ranking within the Market for COVID-19 Diagnostics, 2020
Table 51: Competitors in the Market for COVID-19 Diagnostics
Table 52: Recent Acquisitions by Players in the Market for COVID-19 Diagnostics, 2016 and 2017
Table 53: Recent Contracts in the Market for COVID-19 Diagnostics, 2020
Table 54: Recent Product Approvals on COVID-19 Diagnostics, 2020
Table 55: Abbott: Financials, 2016-2019
Table 56: Abbott: Product Portfolio, by Business Segment
Table 57: Abbott: Rhythm Management Products, 2018
Table 58: Abbott: Recent Developments, April 2015-April 2020
Table 59: Becton, Dickinson and Co.: Financials, 2019
Table 60: Becton, Dickinson and Co.: Product Portfolio
Table 61: Becton, Dickinson and Co.: Bioscience Cell Culture Product Portfolio
Table 62: Becton, Dickinson and Co.: Recent Developments, August 2015-April 2020
Table 63: BioMerieux SA: Financials, 2018
Table 64: BioMerieux SA: Products and Services
Table 65: BioMerieux SA: Recent Developments, November 2018-March 2020
Table 66: Bio-Rad Laboratories Inc.: Financials, 2019
Table 67: Bio-Rad Laboratories Inc.: Products and Services
Table 68: Bio-Rad Laboratories Inc.: Recent Developments, January 2018-May 2020
Table 69: Danaher Corp.: Product Portfolio
Table 70: Danaher Corp.: Financials, 2019
Table 71: Danaher Corp.: Products and Services
Table 72: Danaher Corp.: Recent Developments, August 2015-March 2020
Table 73: F. Hoffmann-La Roche Ltd.: Financials, 2019
Table 74: F. Hoffmann-La Roche Ltd.: Revenues, by Segment, 2016-2018
Table 75: F. Hoffmann-La Roche Ltd.: Revenue, by Diagnostic Segment, 2016-2018
Table 76: F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 77: F. Hoffmann-La Roche Ltd.: Diagnostics Patient Monitoring Product Portfolio
Table 78: F. Hoffmann-La Roche Ltd.: Recent Developments, January 2015-April 2020
Table 79: GenMark Diagnostics Inc.: Key Products
Table 80: GenMark Diagnostics Inc.: COVID Diagnostic Product
Table 81: Glenmark Diagnostics Inc.: Financials, 2019
Table 82: Glenmark Diagnostics Inc.: Recent Developments, March 2020
Table 83: Hologic Inc.: Financials, 2019
Table 84: Hologic Inc.: Recent Developments and Strategies, March 2017-March 2020
Table 85: Qiagen NV: Financials, 2016 and 2017
Table 86: Qiagen NV: Products and Services
Table 87: Siemens Healthcare AG: Key Products
Table 88: Siemens Healthcare AG: Product Segments
Table 89: Siemens Healthcare AG: Financials, 2019
Table 90: Siemens Healthcare AG: Recent Developments, March 2016-March 2020
Table 91: Thermo Fisher Scientific Inc.: Financials, 2018-2019
Table 92: Thermo Fisher Scientific Inc.: Products and Services
Table 93: Acronyms Used in This Report
LIST OF FIGURES
Summary Figure A: Global Market Shares of COVID-19 Diagnostics, by Type, 2020
Summary Figure B: Global Market Shares of COVID-19 Diagnostics, by Technology, 2020
Figure 1: Infographic Comparison of the CFRs of the Three Major Beta Coronaviruses: MERS, SARS and COVID-19
Figure 2: Distribution of Clinical Trials on COVID-19, by Phase
Figure 3: Distribution of Clinical Trials on COVID-19, by Intervention
Figure 4: Distribution of Clinical Trials on COVID-19, by Country
Figure 5: Comparison of GDP Growth Globally, 2019 vs. 2020
Figure 6: Global Healthcare Performance, by Financial Times Stock Exchange (FTSE)
Figure 7: Distribution of the Disruption of Clinical Trials Due to COVID-19, by Therapeutic Area
Figure 8: Global Market Shares of COVID-19 Diagnostics, by Type, 2020
Figure 9: Global Market for COVID-19 Molecular Tests, 2020-2027
Figure 10: Global Market for COVID-19 Molecular Tests, by Region, 2020-2027
Figure 11: Global Market for COVID-19 Serological Tests, 2020-2027
Figure 12: Global Market for COVID-19 Serological Tests, by Region, 2020-2027
Figure 13: Global Market Shares of COVID-19 Diagnostics, by Technology, 2020
Figure 14: Global Market for COVID-19 RT-PCR Diagnostics, 2020-2027
Figure 15: Global Market for COVID-19 RT-PCR Diagnostics, by Region, 2020-2027
Figure 16: Global Market for COVID-19 Isothermal Amplification Diagnostics, 2020-2027
Figure 17: Global Market for COVID-19 Isothermal Amplification Diagnostics, by Region, 2020-2027
Figure 18: Global Market for COVID-19 CRISPR Diagnostics, 2020-2027
Figure 19: Global Market for COVID-19 CRISPR Diagnostics, by Region, 2020-2027
Figure 20: Global Market for COVID-19 ELISA Diagnostics, 2020-2027
Figure 21: Global Market for COVID-19 ELISA Diagnostics, by Region, 2020-2027
Figure 22: Global Market for COVID-19 Hybridization Diagnostics, 2020-2027
Figure 23: Global Market for COVID-19 Hybridization Diagnostics, by Region, 2020-2027
Figure 24: Global Market for Other Types of COVID-19 Diagnostics, 2020-2027
Figure 25: Global Market for Other Types of COVID-19 Diagnostics, by Region, 2020-2027
Figure 26: Global Market Shares of COVID-19 Diagnostics, by End User, 2020
Figure 27: Global Market for COVID-19 Diagnostics in Hospitals, 2020-2027
Figure 28: Global Market for COVID-19 Diagnostics in Hospitals, by Region, 2020-2027
Figure 29: Global Market for COVID-19 Diagnostics in Public Health Laboratories, 2020-2027
Figure 30: Global Market for COVID-19 Diagnostics in Public Health Laboratories, by Region, 2020-2027
Figure 31: Global Market for COVID-19 Diagnostics in Public Health Laboratories, 2020-2027
Figure 32: Global Market for COVID-19 Diagnostics in Private Laboratories, by Region, 2020-2027
Figure 33: Global Market for COVID-19 Diagnostics in the Other End-User Segment, 2020-2027
Figure 34: Global Market for COVID-19 Diagnostics in the Other End-User Segment, by Region, 2020-2027
Figure 35: Global Market Shares of COVID-19 Diagnostics, by Region, 2020
Figure 36: European Market Shares of COVID-19 Diagnostics, by Sub-region, 2020
Figure 37: European Market Shares of COVID-19 Diagnostics, by Type, 2020
Figure 38: Western European Market Shares of COVID-19 Diagnostics, by Country, 2020
Figure 39: U.K. Market for COVID-19 Diagnostics, 2020-2027
Figure 40: Spanish Market for COVID-19 Diagnostics, 2020-2027
Figure 41: German Market for COVID-19 Diagnostics, 2020-2027
Figure 42: Italian Market for COVID-19 Diagnostics, 2020-2027
Figure 43: French Market for COVID-19 Diagnostics, 2020-2027
Figure 44: Rest of Western European Market for COVID-19 Diagnostics, 2020-2027
Figure 45: Eastern European Market for COVID-19 Diagnostics, 2020-2027
Figure 46: North American Market Shares of COVID-19 Diagnostics, by Type, 2020
Figure 47: North American Market Shares of COVID-19 Diagnostics, by Country, 2020
Figure 48: U.S. Market for COVID-19 Diagnostics, 2020-2027
Figure 49: Canadian Market for COVID-19 Diagnostics, 2020-2027
Figure 50: Asia-Pacific Market Shares of COVID-19 Diagnostics, by Type, 2020
Figure 51: Asia-Pacific Market Shares of COVID-19 Diagnostics, by Country, 2020
Figure 52: Indian Market for COVID-19 Diagnostics, 2020-2027
Figure 53: Australian Market for COVID-19 Diagnostics, 2020-2027
Figure 54: South Korean Market for COVID-19 Diagnostics, 2020-2027
Figure 55: Japanese Market for COVID-19 Diagnostics, 2020-2027
Figure 56: Chinese Market for COVID-19 Diagnostics, 2020-2027
Figure 57: Rest of Asia-Pacific Market for COVID-19 Diagnostics, 2020-2027
Figure 58: Latin American Market for COVID-19 Diagnostics, 2020-2027
Figure 59: Latin American Market Shares of COVID-19 Diagnostics, by Type, 2020
Figure 60: Middle Eastern and African Market for COVID-19 Diagnostics, 2020-2027
Figure 61: Middle Eastern and African Market Shares of COVID-19 Diagnostics, by Type, 2020
Figure 62: Abbott: Revenue Share, by Region, 2019
Figure 63: Abbott: Revenue Share, by Business Segment, 2019
Figure 64: Abbott: R&D Expenditure, 2015-2019
Figure 65: Becton, Dickinson and Co.: Revenue Share, by Business Unit, 2019
Figure 66: Becton, Dickinson and Co.: Revenue Share, by Region, 2019
Figure 67: BioMerieux SA: Revenue, by Business Segment, 2015-2017
Figure 68: BioMerieux SA: Revenue, by Region, 2015-2017
Figure 69: Bio-Rad Laboratories Inc.: Revenue, by Business Segment, 2015-2019
Figure 70: Bio-Rad Laboratories Inc.: Revenue, by Region, 2015-2019
Figure 71: Bio-Rad Laboratories Inc.: Revenue Share, by Region, 2019
Figure 72: Danaher Corp.: Revenue Share, by Segment, 2019
Figure 73: Danaher Corp.: Revenue Share, by Region, 2019
Figure 74: F. Hoffmann-La Roche Ltd.: Revenue Share, by Segment, 2019
Figure 75: F. Hoffmann-La Roche Ltd.: Revenue Share, by Region, 2019
Figure 76: Glenmark Diagnostics Inc.: Revenue Share, by Business Segment, 2019
Figure 77: Hologic Inc.: Financials, 2014-2019
Figure 78: Hologic Inc.: Revenue Share, by Region, 2019
Figure 79: Hologic Inc.: Revenue Share, by Segment, 2019
Figure 80: Qiagen NV: Net Sales Share, by Region, 2017
Figure 81: Siemens Healthcare AG: Revenue Share, by Business Segment, 2019
Figure 82: Siemens Healthcare AG: Revenue Share, by Region, 2019
Figure 83: Thermo Fisher Scientific Inc.: Revenue Share, by Business Segment, 2019
Summary Figure A: Global Market Shares of COVID-19 Diagnostics, by Type, 2020
Summary Figure B: Global Market Shares of COVID-19 Diagnostics, by Technology, 2020
Figure 1: Infographic Comparison of the CFRs of the Three Major Beta Coronaviruses: MERS, SARS and COVID-19
Figure 2: Distribution of Clinical Trials on COVID-19, by Phase
Figure 3: Distribution of Clinical Trials on COVID-19, by Intervention
Figure 4: Distribution of Clinical Trials on COVID-19, by Country
Figure 5: Comparison of GDP Growth Globally, 2019 vs. 2020
Figure 6: Global Healthcare Performance, by Financial Times Stock Exchange (FTSE)
Figure 7: Distribution of the Disruption of Clinical Trials Due to COVID-19, by Therapeutic Area
Figure 8: Global Market Shares of COVID-19 Diagnostics, by Type, 2020
Figure 9: Global Market for COVID-19 Molecular Tests, 2020-2027
Figure 10: Global Market for COVID-19 Molecular Tests, by Region, 2020-2027
Figure 11: Global Market for COVID-19 Serological Tests, 2020-2027
Figure 12: Global Market for COVID-19 Serological Tests, by Region, 2020-2027
Figure 13: Global Market Shares of COVID-19 Diagnostics, by Technology, 2020
Figure 14: Global Market for COVID-19 RT-PCR Diagnostics, 2020-2027
Figure 15: Global Market for COVID-19 RT-PCR Diagnostics, by Region, 2020-2027
Figure 16: Global Market for COVID-19 Isothermal Amplification Diagnostics, 2020-2027
Figure 17: Global Market for COVID-19 Isothermal Amplification Diagnostics, by Region, 2020-2027
Figure 18: Global Market for COVID-19 CRISPR Diagnostics, 2020-2027
Figure 19: Global Market for COVID-19 CRISPR Diagnostics, by Region, 2020-2027
Figure 20: Global Market for COVID-19 ELISA Diagnostics, 2020-2027
Figure 21: Global Market for COVID-19 ELISA Diagnostics, by Region, 2020-2027
Figure 22: Global Market for COVID-19 Hybridization Diagnostics, 2020-2027
Figure 23: Global Market for COVID-19 Hybridization Diagnostics, by Region, 2020-2027
Figure 24: Global Market for Other Types of COVID-19 Diagnostics, 2020-2027
Figure 25: Global Market for Other Types of COVID-19 Diagnostics, by Region, 2020-2027
Figure 26: Global Market Shares of COVID-19 Diagnostics, by End User, 2020
Figure 27: Global Market for COVID-19 Diagnostics in Hospitals, 2020-2027
Figure 28: Global Market for COVID-19 Diagnostics in Hospitals, by Region, 2020-2027
Figure 29: Global Market for COVID-19 Diagnostics in Public Health Laboratories, 2020-2027
Figure 30: Global Market for COVID-19 Diagnostics in Public Health Laboratories, by Region, 2020-2027
Figure 31: Global Market for COVID-19 Diagnostics in Public Health Laboratories, 2020-2027
Figure 32: Global Market for COVID-19 Diagnostics in Private Laboratories, by Region, 2020-2027
Figure 33: Global Market for COVID-19 Diagnostics in the Other End-User Segment, 2020-2027
Figure 34: Global Market for COVID-19 Diagnostics in the Other End-User Segment, by Region, 2020-2027
Figure 35: Global Market Shares of COVID-19 Diagnostics, by Region, 2020
Figure 36: European Market Shares of COVID-19 Diagnostics, by Sub-region, 2020
Figure 37: European Market Shares of COVID-19 Diagnostics, by Type, 2020
Figure 38: Western European Market Shares of COVID-19 Diagnostics, by Country, 2020
Figure 39: U.K. Market for COVID-19 Diagnostics, 2020-2027
Figure 40: Spanish Market for COVID-19 Diagnostics, 2020-2027
Figure 41: German Market for COVID-19 Diagnostics, 2020-2027
Figure 42: Italian Market for COVID-19 Diagnostics, 2020-2027
Figure 43: French Market for COVID-19 Diagnostics, 2020-2027
Figure 44: Rest of Western European Market for COVID-19 Diagnostics, 2020-2027
Figure 45: Eastern European Market for COVID-19 Diagnostics, 2020-2027
Figure 46: North American Market Shares of COVID-19 Diagnostics, by Type, 2020
Figure 47: North American Market Shares of COVID-19 Diagnostics, by Country, 2020
Figure 48: U.S. Market for COVID-19 Diagnostics, 2020-2027
Figure 49: Canadian Market for COVID-19 Diagnostics, 2020-2027
Figure 50: Asia-Pacific Market Shares of COVID-19 Diagnostics, by Type, 2020
Figure 51: Asia-Pacific Market Shares of COVID-19 Diagnostics, by Country, 2020
Figure 52: Indian Market for COVID-19 Diagnostics, 2020-2027
Figure 53: Australian Market for COVID-19 Diagnostics, 2020-2027
Figure 54: South Korean Market for COVID-19 Diagnostics, 2020-2027
Figure 55: Japanese Market for COVID-19 Diagnostics, 2020-2027
Figure 56: Chinese Market for COVID-19 Diagnostics, 2020-2027
Figure 57: Rest of Asia-Pacific Market for COVID-19 Diagnostics, 2020-2027
Figure 58: Latin American Market for COVID-19 Diagnostics, 2020-2027
Figure 59: Latin American Market Shares of COVID-19 Diagnostics, by Type, 2020
Figure 60: Middle Eastern and African Market for COVID-19 Diagnostics, 2020-2027
Figure 61: Middle Eastern and African Market Shares of COVID-19 Diagnostics, by Type, 2020
Figure 62: Abbott: Revenue Share, by Region, 2019
Figure 63: Abbott: Revenue Share, by Business Segment, 2019
Figure 64: Abbott: R&D Expenditure, 2015-2019
Figure 65: Becton, Dickinson and Co.: Revenue Share, by Business Unit, 2019
Figure 66: Becton, Dickinson and Co.: Revenue Share, by Region, 2019
Figure 67: BioMerieux SA: Revenue, by Business Segment, 2015-2017
Figure 68: BioMerieux SA: Revenue, by Region, 2015-2017
Figure 69: Bio-Rad Laboratories Inc.: Revenue, by Business Segment, 2015-2019
Figure 70: Bio-Rad Laboratories Inc.: Revenue, by Region, 2015-2019
Figure 71: Bio-Rad Laboratories Inc.: Revenue Share, by Region, 2019
Figure 72: Danaher Corp.: Revenue Share, by Segment, 2019
Figure 73: Danaher Corp.: Revenue Share, by Region, 2019
Figure 74: F. Hoffmann-La Roche Ltd.: Revenue Share, by Segment, 2019
Figure 75: F. Hoffmann-La Roche Ltd.: Revenue Share, by Region, 2019
Figure 76: Glenmark Diagnostics Inc.: Revenue Share, by Business Segment, 2019
Figure 77: Hologic Inc.: Financials, 2014-2019
Figure 78: Hologic Inc.: Revenue Share, by Region, 2019
Figure 79: Hologic Inc.: Revenue Share, by Segment, 2019
Figure 80: Qiagen NV: Net Sales Share, by Region, 2017
Figure 81: Siemens Healthcare AG: Revenue Share, by Business Segment, 2019
Figure 82: Siemens Healthcare AG: Revenue Share, by Region, 2019
Figure 83: Thermo Fisher Scientific Inc.: Revenue Share, by Business Segment, 2019
